61703-343 : Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate


NDC61703-343
Labeler: Hospira Worldwide, Inc.
Product Type: Human Prescription Drug
Drug Name:  Mitoxantrone
Dosage Form: Intravenous Injection, Solution, Concentrate
Application #: ANDA076871
Rev. Date: 


NDC Package Codes:

  • 61703-343-18: 10 ML IN 1 VIAL, MULTI‑DOSE (61703‑343‑18)
  • 61703-343-65: 12.5 ML IN 1 VIAL, MULTI‑DOSE (61703‑343‑65)
  • 61703-343-66: 15 ML IN 1 VIAL, MULTI‑DOSE (61703‑343‑66)

Active Ingredients:

  • Mitoxantrone Hydrochloride

Dosage Strength:

  • 2 mg/mL

Pharmaceutical Classes:

  • Topoisomerase Inhibitor [EPC]
  • Topoisomerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0703-4680 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc
  • 0703-4685 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc
  • 0703-4686 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc
  • 55390-083 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
  • 55390-084 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
  • 55390-085 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
  • 63323-132 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by App Pharmaceuticals, LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 61703-343 QR Code

< Prev: 61703-342Next: 61703-344 >




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.